We present here the case of a 30-year-old man with a long term history of nephrotic syndrome (NS) who developed an episode of acute left main pulmonary artery thrombosis complicated by a lung abscess. During the hospital admission was also identified a concomitant hyperhomocysteinemia. After an atypical resection of the left upper pulmonary lobe and the starting of long term anticoagulation the patient was discharged but did not attend the planned follow up visits until one year later when he was seen again for severe dyspnea and exercise intolerance. At this time chronic thromboembolic pulmonary hypertension (CTEPH) was diagnosed by lung perfusion scintigraphy and right heart catheterization. He initially refused the surgical treatment but, after six months, for the presence of worsening dyspnea was referred for bilateral pulmonary endarterectomy followed by a cardio-thoracic rehabilitation program. After a follow-up of seven years the patient is alive and in stable conditions. NS and hyperhomocysteinemia are both known risk factors for pulmonary embolism (PE), but their association with CTEPH is extremely rare. We discuss here the possible mechanisms linking these conditions. CTEPH must be suspected in any patient with NS, with or without hyperhomocysteinemia, and unexplained dyspnea.
Introduction
Thromboembolism is one of the major complications of nephrotic syndrome (NS) [1] . In particular, the presence of pulmonary artery thrombosis is often fatal [2] . Hyperhomocysteinemia is another accepted risk factor for pulmonary thromboembolism [3] . Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare condition presenting in 2-4% of patients after acute pulmonary embolism but characterized by significant morbidity and mortality [4, 5] . The association of NS and hyperhomocysteinemia with CTEPH is extremely rare.
Case Report
The case concerns a 30-year-old (height 160 cm, weight 60 Kg, body mass index 23 Kg/m 2 ) Caucasian man, medical doctor, who presented at the emergency department of our University Hospital of Messina, Italy (www.polime.it) for the presence by 30 days of persistent dry cough associated in the last 7 days with exercise-induced dyspnea and bilateral pitting edema of the ankles. He was a current smoker of 3 pack-years, with of a history of minimal change nephrotic syndrome diagnosed (with a kidney biopsy) 20 years before the presentation and treated with low dose oral glucocorticoid (5 mg daily of prednisone equivalent) therapy from childhood. He was under regular treatment with diuretic (25 mg once daily furosemide) and proton pump inhibitor (20 mg once daily of omeprazole) for systemic arterial hypertension and gastroesophageal reflux diagnosed 5 years before the presentation. Case Report pime pime pime pime p pi im me e EDITRICE enoxaparin (1 mg/Kg). A duplex ultrasonography of the venous system of the lower legs was normal. The pathological routine laboratory tests are shown in Table 1 . The most relevant abnormality was the presence of hyperhomocysteinemia with an homozygous T-variant of the common methylenetetrahydrofolate reductase (MTHFR) 677C→T polymorphism in the MTHFR gene. The lung abscess did not improve despite 15 days of treatment with adequate empiric wide spectrum antibiotic treatment (piperacillin/tazobactam 3.375 g IV every 6 hours). For this reason, the thoracic surgeon performed an atypical resection of the left upper pulmonary lobe. At the hospital discharge, after 21 days from his admission, the patient was in stable conditions with only residual exercise dyspnea (Borg scale 2) but without cough, chest pain, fever and/or peripheral edema. At the discharge he was under regular treatment with warfarin (with a target INR of 2.0-3.0) together with his previous regular pharmacological treatment (oral prednisone 5 mg and furosemide 25 mg, both once daily). The patient did not attend our clinic for the planned three and six months follow-up visits but he presented spontaneously at our clinic again ~12 months after his hospital discharge reporting worsening exercise dyspnea (Borg scale 5). The
One month before the current admission he had been treated intramuscularly for seven days at home by his General Practitioner with ceftriaxone (1 gram/once daily) for the presence of cough with yellow sputum, diffuse thoracic pain and fever (37.5°C). At the admission, the patient presented with dyspnea (Borg scale 4) and oxygen desaturation (92% when breathing room air). Blood gas test on room air was: pH 7.50, PaO2 60 mmHg; PaCO2 35 mmHg, HCO3-28,5 mmol/L, BE + 4,6, Sat 93%; Physical examination of the chest revealed only the presence of an hypophonesis in the left upper lobe. No other physical signs outside the chest were pathological. An x-ray of the chest showed the presence of a cavitated mass (10 cm of diameter) located in the upper left lobe with a frank air-fluid level ( Figure 1) . A computed tomography (CT) scan of the chest, performed before and after the administration of contrast medium, confirmed the presence of an excavated lesion in the upper left lobe of the lungs associated to the partial occlusion of the left main pulmonary artery containing a thrombus inside the lumen (Figure 1 ). These lesions were interpreted as a pulmonary infarction with a superimposed lung abscess secondary to left main pulmonary artery thrombosis. Immediately the patient was placed on twice daily Case Report pime pime pime pime p pi im me e EDITRICE Case Report pime pime pime pime p pi im me e EDITRICE
Discussion
An association between hypercoagulability and nephrotic syndrome (NS), which is characterized by heavy proteinuria, hypoalbuminemia, hyperlipidemia and edema, has been established many years ago [6, 7] . This hypercoagulable state is likely caused by multiple factors, including platelet activation and aggregation, hyperfibrinogenemia, loss of antithrombin, hypoplasminogenemia and increased levels of plasminogen activator inhibitor [7] . The prevalence of pulmonary embolism in nephrotic patients has been greatly different among studies and can be asymptomatic or even lethal [6] . Although the MTHFR 677C->T polymorphism increases the homocysteine levels, the association between clinical suspicion of chronic thromboembolic pulmonary hypertension was confirmed using lung perfusion scintigraphy and the right hearth catheterization (Figure 2) . The mean pulmonary artery pressure at rest was 46 mmHg (normal value 9-18 mmHg). The patient refused to perform an evaluation at a cardiothoracic surgery referral center at the University Hospital of Pavia, Italy. However, after six months and a further deterioration of the dyspnea he accepted to be referred to this center for a bilateral pulmonary endarterectomy. The surgical intervention was uneventful and followed by clinical and functional improvement. After three months of a cardio-thoracic rehabilitation program the patient was discharged at home. The pre-and postoperative spirometry are shown in Figure 3 . After a follow-up of seven years the patient is alive and in stable conditions. Case Report pime pime pime pime p pi im me e EDITRICE this polymorphism and an increased risk of pulmonary thromboembolism is controversial [3, [8] [9] [10] . It is, possible that hyperhomocysteinemia led to venous thrombosis, with secondary embolism in the patient's pulmonary circulation. Vascular endothelial necrosis caused by extremely high homocysteine levels might have caused localized thrombus formation in the vascular tree. Nevertheless, duplex ultrasonography and a CT scan did not detect deep vein thrombosis in the patient's legs, abdomen or pelvis of this patient as previously demonstrated in another case report [11] . Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare but life-threatening complication of pulmonary embolism and is defined as precapillary pulmonary hypertension (mean pulmonary artery pressure ≥25 mmHg with a pulmonary capillary wedge pressure ≤15 mmHg) associated with mismatched perfusion defects on ventilation-perfusion lung scan and signs of chronic thromboembolic disease on computed tomography pulmonary angiogram and/or conventional pulmonary angiography, in a patient who received at least 3 months of therapeutic anticoagulation [5] . The diagnostic work-up to detect or rule out CTEPH should include ventilationperfusion scintigraphy, which has high sensitivity and a negative predictive value of nearly 100%. Patients with suspected CTEPH should be referred to a specialist centre for right-heart catheterization and pulmonary angiography. Surgical pulmonary endarterectomy is still the treatment of choice for CTEPH and is associated with excellent longterm results and a high probability of cure [4] . Although several studies have shown that homocysteine levels can be reduced by vitamin supplementation, it has yet to be proven that this reduction leads to a reduced risk of cardiovascular morbidity and mortality [12] .
Conclusions
In summary, we describe an unusual case of a 30-year-old man with nephrotic syndrome from childhood and concomitant occult hyperhomocysteinemia who presented with pulmonary artery thrombosis and lung abscess that evolved in a chronic thromboembolic pulmonary hypertension successfully treated with bilateral pulmonary endarterectomy. CPEPH must be suspected in any patient with NS, with or without hyperhomocysteinemia, and unexplained dyspnea. 
